Stay updated on Nivolumab for Uterine Cancer - Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Uterine Cancer - Clinical Trial page.

Latest updates to the Nivolumab for Uterine Cancer - Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedPage revision tag updated to v3.5.0, replacing the previous v3.4.3. This appears to be a minor maintenance update unrelated to study data or usability.SummaryDifference0.1%

- Check22 days agoChange DetectedThe page's revision label has been updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check51 days agoChange DetectedAdded Revision: v3.4.2. Removed earlier notices including Revision: v3.4.1 and the government funding status notice with links to operating status.SummaryDifference0.4%

- Check58 days agoChange DetectedNotice about government funding lapse and NIH Clinical Center operating status added; revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check65 days agoChange DetectedAdded a glossary toggle and updated QC/versioning labels: 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while removing the older forms 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check79 days agoChange DetectedRevision tag updated to v3.3.4, replacing v3.3.3. This is a minor site maintenance change and does not alter the study details, eligibility criteria, or user actions on the page.SummaryDifference0.1%

Stay in the know with updates to Nivolumab for Uterine Cancer - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Uterine Cancer - Clinical Trial page.